Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 14Blood Pressure and Hypertension StudiesChronic Kidney Disease and DiabetesRenin-Angiotensin System Studies

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Renoprotective Effect of Calcium Channel Blockers in Combination with an Angiotensin Receptor Blocker in Elderly Patients with Hypertension. A Randomized Crossover Trial Between Benidipine and Amlodipine

Abstract

Anti-hypertensive medication with an angiotensin II receptor blocker (ARB) is effective in slowing the progression of chronic kidney disease. The present study was designed to investigate whether calcium channel blockers (CCBs) in combination with an ARB differentially affect kidney function. Elderly hypertensive patients with chronic kidney disease (n = 17, 72 +/- 6 years old) were instructed to self-measure blood pressure. They were randomly assigned to receive either benidipine (4-8 mg/day) or amlodipine (5-10 mg/day) combined with olmesartan (10 mg/day). After 3 months, CCBs were switched in each patient and the same protocol was applied for another 3 months. At baseline, significant correlation was obtained between urine albumin (22.8 +/- 16.7 (median +/- median absolute deviation) mg/g creatinine) and self-measured blood pressure (170 +/- 23/87 +/- 10 (mean +/- SD) mmHg, r = 0.65, p < 0.01). Both regimens reduced blood pressure to a similar extent (139 +/- 22/75 +/- 11 mmHg and 133 +/- 17/72 +/- 10 mmHg, respectively; both p < 0.001), while urine albumin decreased only after combination therapy including benidipine (11.7 +/- 6.1 mg/g creatinine, p < 0.05). Benidipine, but not amlodipine, in combination with olmesartan, reduced urinary albumin excretion in elderly hypertensive patients with chronic kidney disease. The results suggest the importance of selecting medications used in combination with ARB in hypertensive patients with chronic kidney disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/10641960902929446

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. 10.1001/jama.1992.03490210067037 · DOI
  2. Fleming JT, 1987, Am J Physiol, 253, F1157
  3. Carmines PK, 1989, Am J Physiol, 256, F1015

Cited by

See all 14

Metadata

Authors
Miyagawa, K., Dohi, Y., Nakazawa, A., Sugiura, T., Yamashita, S., Sato, K., & Kimura, G.
Affiliations
Nagoya City University (JP)
Corresponding author
Dohi, Yasuaki
Venue
Clinical and Experimental Hypertension
Published
2010-02
Volume
32
Issue
1
Pages
1-7
ISSN
  • 0148-3927 (ISSN-L)
  • 1064-1963
  • 1525-6006
OpenAlex
W2111641755
Cited by
14
References
51
Citations by year
2025: 1 · 2020: 1 · 2016: 1 · 2015: 2 · 2013: 1 · 2012: 1
FWCI
1.98
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical and Experimental Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords
renal protection, calcium channel blockers, angiotensin receptor blockers, benidipine, amlodipine, olmesartan, chronic kidney disease, hypertension, elderly patients, urinary albumin excretion, combination antihypertensive therapy, blood pressure reduction
MeSH terms
Aged, Aged, 80 and over, Albuminuria, Antihypertensive Agents, Blood Pressure, Calcium Channel Blockers, Dihydropyridines, Drug Therapy, Combination, Female, Humans, Hypertension, Imidazoles, Male, Tetrazoles, Amlodipine, Cross-Over Studies, Angiotensin II Type 1 Receptor Blockers, Renal Insufficiency, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.